Compile Data Set for Download or QSAR
Report error Found 2075 Enz. Inhib. hit(s) with Target = 'P2X purinoceptor 2' Sort by
TargetP2X purinoceptor 2(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50118220(adenosine(5')tetraphospho(5')adenosine | P(1),P(4)...)
Affinity DataEC50:  1.50E+4nMAssay Description:The compound was evaluated for antagonist activity against recombinant human receptor P2X purinoceptor 2 (P2X2 )More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2012
Entry Details Article
PubMed
TargetP2X purinoceptor 2(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50370141(TNP-ATP)
Affinity DataEC50:  2.00E+3nMAssay Description:The compound was evaluated for antagonist activity against recombinant human receptor P2X purinoceptor 2 (P2X2)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2012
Entry Details Article
PubMed
TargetP2X purinoceptor 2(Rat)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50064803(MRS 2220 | 3-Methyl-7-oxo-5,9-dihydro-6,8-dioxa-2-...)
Affinity DataEC50:  1.00E+5nMAssay Description:The compound was evaluated for antagonist activity against recombinant rat P2X purinoceptor 2 (P2X2) at 30 uMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2012
Entry Details Article
PubMed
TargetP2X purinoceptor 2(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50368125(ADP | ADENOSINE DIPHOSPHATE)
Affinity DataEC50: >1.00E+5nMAssay Description:The compound was evaluated for antagonist activity against recombinant human receptor P2X purinoceptor 2 (P2X2 )More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2012
Entry Details Article
PubMed
TargetP2X purinoceptor 2(Rat)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50118232(ATP, 2-meS | CHEMBL336208 | 2-MeSATP)
Affinity DataEC50:  1.50E+3nMAssay Description:The compound was evaluated for antagonist activity against recombinant rat receptor P2X purinoceptor 2 (P2X2) at 10 uM, expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2012
Entry Details Article
PubMed
TargetP2X purinoceptor 2(Rat)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50366480(ATP | ADENOSINE TRIPHOSPHATE)
Affinity DataEC50:  1.40E+3nMAssay Description:The compound was evaluated for antagonist activity against recombinant rat receptor P2X purinoceptor 2 (P2X2) at 10 uM, expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2012
Entry Details Article
PubMed
TargetP2X purinoceptor 2(Rat)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50118226(PAPET-ATP | CHEMBL337062)
Affinity DataEC50:  1.00E+4nMAssay Description:The compound was evaluated for antagonist activity against recombinant rat receptor P2X purinoceptor 2 (P2X4) at 30 uM, expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2012
Entry Details Article
PubMed
TargetP2X purinoceptor 2(Rat)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50118229(MRS 2179 | CHEMBL129841)
Affinity DataEC50: >1.00E+4nMAssay Description:The compound was evaluated for antagonist activity against recombinant rat receptor P2X purinoceptor 2 (P2X2) at 10 uM, expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2012
Entry Details Article
PubMed
TargetP2X purinoceptor 2(Rat)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50118217(PHOSPHOTHIOPHOSPHORIC ACID-ADENYLATE ESTER | ATPga...)
Affinity DataEC50:  1.50E+3nMAssay Description:The compound was evaluated for antagonist activity against recombinant rat receptor P2X purinoceptor 2 (P2X2) at 10 uM, expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2012
Entry Details Article
PubMed
TargetP2X purinoceptor 2(Rat)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50118240(((2R,3S,4R,5R)-5-(6-amino-2-(hexylthio)-9H-purin-9...)
Affinity DataEC50:  1.80E+5nMAssay Description:The compound was evaluated for antagonist activity against recombinant rat receptor P2X purinoceptor 2 (P2X4) at 30 uM, expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2012
Entry Details Article
PubMed
TargetP2X purinoceptor 2(Rat)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM85043(CHEMBL69234 | CAS_149017-66-3 | NSC_6093163 | PPAD...)
Affinity DataEC50:  1.20E+4nMAssay Description:The compound was evaluated for antagonist activity against recombinant rat receptor P2X purinoceptor 2 (P2X2) at 30 uM, expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2012
Entry Details Article
PubMed
TargetP2X purinoceptor 2(Rat)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50336799(Suramin hexasodium | Germanin | suramin | 8,8'-[Ca...)
Affinity DataEC50:  1.04E+4nMAssay Description:The compound was evaluated for antagonist activity against recombinant rat receptor P2X purinoceptor 2 (P2X2) at 30 uM, expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2012
Entry Details Article
PubMed
TargetP2X purinoceptor 2(Rat)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50029031(CHEMBL223344 | 1-Amino-4-{4-[4-chloro-6-(3-sulfo-p...)
Affinity DataEC50:  360nMAssay Description:The compound was evaluated for antagonist activity against recombinant rat receptor P2X purinoceptor 2 (P2X2) at 10 uM, expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2012
Entry Details Article
PubMed
TargetP2X purinoceptor 2(Rat)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50118243(MRS 2191 | CHEMBL334823)
Affinity DataEC50:  1.10nMAssay Description:The compound was evaluated for antagonist activity against recombinant rat receptor P2X purinoceptor 2 (P2X2) at 10 uM, expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2012
Entry Details Article
PubMed
TargetP2X purinoceptor 2(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50118219(Bz-ATP | CHEMBL339386)
Affinity DataEC50:  5.50E+3nMAssay Description:The compound was evaluated for antagonist activity against recombinant human receptor P2X purinoceptor 2 (P2X2 )More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2012
Entry Details Article
PubMed
TargetP2X purinoceptor 2(Rat)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50118221(alpha,beta-meATP | DIPHOSPHOMETHYLPHOSPHONIC ACID ...)
Affinity DataEC50:  1.00E+5nMAssay Description:The compound was evaluated for antagonist activity against recombinant rat receptor P2X purinoceptor 2 (P2X2) at 10 uM, expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2012
Entry Details Article
PubMed
TargetP2X purinoceptor 2(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50118216((4-formyl-5-hydroxy-6-methylpyridin-3-yl)methyl di...)
Affinity DataEC50:  3.95E+4nMAssay Description:The compound was evaluated for antagonist activity against recombinant human receptor P2X purinoceptor 2 (P2X2 )More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2012
Entry Details Article
PubMed
TargetP2X purinoceptor 2(Rat)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50118230(5'-O-[(R)-HYDROXY(THIOPHOSPHONOOXY)PHOSPHORYL]ADEN...)
Affinity DataEC50:  1.00E+5nMAssay Description:The compound was evaluated for antagonist activity against recombinant rat receptor P2X purinoceptor 2 (P2X2) at 10 uM, expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2012
Entry Details Article
PubMed
TargetP2X purinoceptor 2(Rat)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50336800(Sodium 1-Amino-4-(3-phenoxyphenylamino)-9,10-dioxo...)
Affinity DataEC50:  489nMAssay Description:Antagonist activity against rat P2X2 receptor expressed in Xenopus laevis oocyte assessed as maximum alpha, beta-meATP-induced inward current by two-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/5/2013
Entry Details Article
PubMed
TargetP2X purinoceptor 2(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50598316(CHEMBL5184613)
Affinity DataEC50:  8.27E+3nMAssay Description:Antagonist activity against human P2X2R stably transfected in human 1321N1 cells assessed as ATP EC50 at 0.1 uM incubated for 30 mins by Fura-2 AM st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetP2X purinoceptor 2(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50598316(CHEMBL5184613)
Affinity DataEC50:  1.09E+4nMAssay Description:Antagonist activity against human P2X2R stably transfected in human 1321N1 cells assessed as ATP EC50 at 0.2 uM incubated for 30 mins by Fura-2 AM st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetP2X purinoceptor 2(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50598316(CHEMBL5184613)
Affinity DataEC50:  1.08E+4nMAssay Description:Antagonist activity against human P2X2R stably transfected in human 1321N1 cells assessed as ATP EC50 at 0.4 uM incubated for 30 mins by Fura-2 AM st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetP2X purinoceptor 2(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50594505(CHEMBL5177316)
Affinity DataEC50: <1.00E+5nMAssay Description:Agonist activity at human P2X2R expressing CHO cells assessed as reduction in intracellular Ca2+ influx pretreated with Fluo-4 for 1 hr followed by c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetP2X purinoceptor 2(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50594506(CHEMBL5183218)
Affinity DataEC50: <1.00E+5nMAssay Description:Agonist activity at human P2X2R expressing CHO cells assessed as reduction in intracellular Ca2+ influx pretreated with Fluo-4 for 1 hr followed by c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetP2X purinoceptor 2/3(Human)
European Institute For Molecular Imaging (Eimi)

Curated by ChEMBL
LigandPNGBDBM50594505(CHEMBL5177316)
Affinity DataEC50:  1.20E+3nMAssay Description:Agonist activity at human P2X2R/P2X3R expressing CHO cells assessed as reduction in intracellular Ca2+ influx pretreated with Fluo-4 for 1 hr followe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetP2X purinoceptor 2/3(Human)
European Institute For Molecular Imaging (Eimi)

Curated by ChEMBL
LigandPNGBDBM50594506(CHEMBL5183218)
Affinity DataEC50: <1.00E+5nMAssay Description:Agonist activity at human P2X2R/P2X3R expressing CHO cells assessed as reduction in intracellular Ca2+ influx pretreated with Fluo-4 for 1 hr followe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetP2X purinoceptor 2(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50594500(CHEMBL5202979)
Affinity DataIC50: 3.70nMAssay Description:Agonist activity at human P2X2R expressing CHO cells assessed as reduction in intracellular Ca2+ influx pretreated with Fluo-4 for 1 hr followed by c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetP2X purinoceptor 2(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50257829(Ro-51 | 2-(4-amino-5-(5-iodo-2-isopropyl-4-methoxy...)
Affinity DataIC50: 5nMAssay Description:Antagonist activity at human P2X2/3 receptor expressed in 1321n1c cells by FLIPRMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetP2X purinoceptor 2/3(Human)
European Institute For Molecular Imaging (Eimi)

Curated by ChEMBL
LigandPNGBDBM50594498(CHEMBL4583478)
Affinity DataIC50: 8.30nMAssay Description:Agonist activity at human P2X2R/P2X3R expressing CHO cells assessed as reduction in intracellular Ca2+ influx pretreated with Fluo-4 for 1 hr followe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetP2X purinoceptor 2(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50413370(CHEMBL495204)
Affinity DataIC50: 13nMAssay Description:Inhibition of P2X2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetP2X purinoceptor 2(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM319936(US10174016, Example 103 | 3-[(2- Methylpyridin- 4-...)
Affinity DataIC50: 14nMAssay Description:A fluorescent imaging plate reader (FLEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
Go to US Patent

TargetP2X purinoceptor 2(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM320093(US10174016, Example 260 | 3-(5-ethyl-1,3- thiazol-...)
Affinity DataIC50: 14nMAssay Description:A fluorescent imaging plate reader (FLEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
Go to US Patent

TargetP2X purinoceptor 2(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM319936(US10174016, Example 103 | 3-[(2- Methylpyridin- 4-...)
Affinity DataIC50: 14nMAssay Description:A fluorescent imaging plate reader (FLEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
Go to US Patent

TargetP2X purinoceptor 2(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM320093(US10174016, Example 260 | 3-(5-ethyl-1,3- thiazol-...)
Affinity DataIC50: 14nMAssay Description:A fluorescent imaging plate reader (FLEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
Go to US Patent

TargetP2X purinoceptor 2/3(Human)
European Institute For Molecular Imaging (Eimi)

Curated by ChEMBL
LigandPNGBDBM319936(US10174016, Example 103 | 3-[(2- Methylpyridin- 4-...)
Affinity DataIC50: 14nMAssay Description:A fluorescent imaging plate reader (FLEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetP2X purinoceptor 2/3(Human)
European Institute For Molecular Imaging (Eimi)

Curated by ChEMBL
LigandPNGBDBM320093(US10174016, Example 260 | 3-(5-ethyl-1,3- thiazol-...)
Affinity DataIC50: 14nMAssay Description:A fluorescent imaging plate reader (FLEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetP2X purinoceptor 2/3(Human)
European Institute For Molecular Imaging (Eimi)

Curated by ChEMBL
LigandPNGBDBM319936(US10174016, Example 103 | 3-[(2- Methylpyridin- 4-...)
Affinity DataIC50: 14nMAssay Description:A fluorescent imaging plate reader (FILEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/14/2020
Entry Details
Go to US Patent

TargetP2X purinoceptor 2/3(Human)
European Institute For Molecular Imaging (Eimi)

Curated by ChEMBL
LigandPNGBDBM320093(US10174016, Example 260 | 3-(5-ethyl-1,3- thiazol-...)
Affinity DataIC50: 14nMAssay Description:A fluorescent imaging plate reader (FILEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/14/2020
Entry Details
Go to US Patent

TargetP2X purinoceptor 2(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50413367(CHEMBL523173)
Affinity DataIC50: 16nMAssay Description:Antagonist activity at human P2X2/3 receptor expressed in 1321n1c cells by FLIPRMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetP2X purinoceptor 2(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50413364(CHEMBL492300)
Affinity DataIC50: 16nMAssay Description:Antagonist activity at human P2X2/3 receptor expressed in 1321n1c cells by FLIPRMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetP2X purinoceptor 2(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM319933(US10174016, Example 100 | N-[(1R)-1-(6- Methyl- py...)
Affinity DataIC50: 16nMAssay Description:A fluorescent imaging plate reader (FLEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
Go to US Patent

TargetP2X purinoceptor 2(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM319933(US10174016, Example 100 | N-[(1R)-1-(6- Methyl- py...)
Affinity DataIC50: 16nMAssay Description:A fluorescent imaging plate reader (FLEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
Go to US Patent

TargetP2X purinoceptor 2/3(Human)
European Institute For Molecular Imaging (Eimi)

Curated by ChEMBL
LigandPNGBDBM319933(US10174016, Example 100 | N-[(1R)-1-(6- Methyl- py...)
Affinity DataIC50: 16nMAssay Description:A fluorescent imaging plate reader (FLEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetP2X purinoceptor 2/3(Human)
European Institute For Molecular Imaging (Eimi)

Curated by ChEMBL
LigandPNGBDBM319933(US10174016, Example 100 | N-[(1R)-1-(6- Methyl- py...)
Affinity DataIC50: 16nMAssay Description:A fluorescent imaging plate reader (FILEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/14/2020
Entry Details
Go to US Patent

TargetP2X purinoceptor 2(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM319940(US10174016, Example 107 | N-[(1R)-1-(6- Methylpyri...)
Affinity DataIC50: 17nMAssay Description:A fluorescent imaging plate reader (FLEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
Go to US Patent

TargetP2X purinoceptor 2(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM319940(US10174016, Example 107 | N-[(1R)-1-(6- Methylpyri...)
Affinity DataIC50: 17nMAssay Description:A fluorescent imaging plate reader (FLEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
Go to US Patent

TargetP2X purinoceptor 2/3(Human)
European Institute For Molecular Imaging (Eimi)

Curated by ChEMBL
LigandPNGBDBM319940(US10174016, Example 107 | N-[(1R)-1-(6- Methylpyri...)
Affinity DataIC50: 17nMAssay Description:A fluorescent imaging plate reader (FLEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetP2X purinoceptor 2/3(Human)
European Institute For Molecular Imaging (Eimi)

Curated by ChEMBL
LigandPNGBDBM319940(US10174016, Example 107 | N-[(1R)-1-(6- Methylpyri...)
Affinity DataIC50: 17nMAssay Description:A fluorescent imaging plate reader (FILEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/14/2020
Entry Details
Go to US Patent

TargetP2X purinoceptor 2(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM319931(US10174016, Example 98 | 3-(5-Methyl- 1,3-thiazol-...)
Affinity DataIC50: 19nMAssay Description:A fluorescent imaging plate reader (FLEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
Go to US Patent

TargetP2X purinoceptor 2(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM319931(US10174016, Example 98 | 3-(5-Methyl- 1,3-thiazol-...)
Affinity DataIC50: 19nMAssay Description:A fluorescent imaging plate reader (FLEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
Go to US Patent

Displayed 1 to 50 (of 2075 total ) | Next | Last >>
Jump to: